Photo - Hera Health Solutions
play_arrow
View
38056

Hera Health Solutions

Hera Health Solutions

USA, Tennessee
Market: Mechanical engineering, Medicine, Pharmacology, Chemistry
Stage of the project: Prototype or product is ready

Date of last change: 04/25/2019
Min investment
$  62.500
Show contacts
Total required
$ 1.250.000
Rating
equalizer 325 из 1000
help
Calculated and estimated occupancy of the project (more about ratings)
My rating
1
2
3
4
5
6
7
8
9
10
Average rating:

Idea

Hera Health Solutions is a pharmaceutical device company specializing in the research, development, and commercialization of long term treatments through proprietary biodegradable implants by using existing generic drugs in combination with already FDA-approved structural materials.

Current Status

Our first product - Eucontra has a fully working prototype and is finalizing preclinical trials to prep for full FDA submission and approval.

Market

Hera's first product, Eucontra aims to join and disrupt the worldwide contraceptive market valued at a $14B industry. Moreover, the long acting drug delivery market which can be utilized through our drug delivery platform is estimated to be valued at over $800B.

Problem or Opportunity

Offering quality and controlled medication over long periods of time is troublesome and requires invasive procedures. Current solutions on the market make it necessary for an expensive and complicated removal procedures. These procedures often leave behind heavy bruising, scarring, and even lost foreign objects in the body.

Solution (product or service)

Proprietary biodegradable drug delivery implants created by using existing generic drugs in combination with already FDA approved structural materials will deliver trusted medication over extended periods of time.

Competitors

Nexplanon
Copper Iud
Depo Provera

Advantages or differentiators

There are currently no products on the market that directly address the removal issuess of the contraceptive arm implant. The pricing of our product is competitive and offer a non invasive, effective, and discreet form.

Finance

Currently raising $1.25 MM Series Seed Round - Lead Investor Secured with leading Healthcare VC

Business model

Technology will be marketed and sold as pharmaceutical products that align with already existing reimbursement codes.

Money will be spent on

1. Non- GLP Preclinical Testing
2. PIND FDA Submission
3. WHO Pre Approval Submission
4. Prepare Clinical Study Preparation

Offer for investor

Full Term sheet available on request

Team or Management

Risks

- FDA regulatory approval necessary for US sales & distribution
- World Health Organization pre-approval necessary for International sales & distribution

Incubation/Acceleration programs accomplishment

Zeroto510 - USA ranked accelerator
BioExel Program

Won the competition and other awards

1. Named Next Emerging Medical Device Innovation at International Competition
2. Startup of Year SXSW Winner
3. Get Started Startup Winner 2018
4. Get Started Medical Startup Winner 2018

Invention/Patent

Bioerodible Drug Delivery implants - patent pending - published patent - all rights assigned to Hera Health Solutions Inc.

Photos

Photo 1 - Hera Health Solutions

Product Video

Website address

5,00
1
2
3
4
5
2 voices
Sign in/Sign up
arrow_back
EN
more_horiz
close
visibility444
star0
Add to favorites
Delete from favorites
share
close
thumb_up0
Like
Unlike
Idea
Current Status
Market
Problem or Opportunity
Solution (product or service)
Competitors
Advantages or differentiators
Finance
Invested in previous rounds, $
Business model
Money will be spent on
Offer for investor
Team or Management
Mentors & Advisors
Lead investor
Risks
Incubation/Acceleration programs accomplishment
Won the competition and other awards
Invention/Patent
Photos
Product Video
Website address